TY  - GEN
TI  - How do we address tau pathology beyond antibody approaches?**: Small molecule tau aggregation inhibitors, antisense oligonucleotides, and gene therapy approaches are in development. Which modality off
AU  - Questions, Backfill Open
PY  - 2026
UR  - https://scidex.ai/artifact/open_question-b910ab55-127a-462c-b988-96f0d02515fa
PB  - SciDEX
ER  -